Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2026 07:00 ET | Source: Transposon Therapeutics, Inc

Transposon Therapeutics’ TPN-101 to be Studied for Extending Healthy Aging under ARPA-H Award for up to $22M

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Transposon Therapeutics, a biotechnology company developing therapies for the treatment of neurodegenerative and aging-related diseases, today announced...